Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | LCK | P06239 | 1/20 | 0.59 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.59 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5920648 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17786 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7990074 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL525378 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL524846 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL338215 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7309478 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL123324 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL4424351 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6242099 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139388-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| EP-4139387-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115461396-A | Additive composition and use thereof, condensation polymer composition, moulding compound and moulded part produced therefrom and use thereof | 弗劳恩霍夫应用研究促进协会 | 2022-12-09 | — | — | CN | claimed |
| WO-2021214207-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-10-28 | — | — | WO | claimed |
| WO-2021213939-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-10-28 | — | — | WO | claimed |
| US-20030113388-A1 | Methods of treatment for skin disorders using turmeric extract and a hydroxy acid | DUNG PHAN | 2003-06-19 | — | — | US | claimed |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | CLOSURE MEDICAL CORPORATION (US) | 2003-05-01 | — | — | US | claimed |
| US-5993832-A | POLYETHERSILOXANE COPOLYMERS CONTAINING PHOSPHATE GROUPS | L'OREAL (FR) | 1999-11-30 | — | — | US | claimed |
| EP-0261812-B1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1991-08-14 | — | — | EP | claimed |
| EP-0261812-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1988-03-30 | — | — | EP | claimed |
| CN-119744285-A | Polyamide resin composition, metal resin joined body, method for producing same, bus bar unit, driving unit, and moving body | 三井化学株式会社 | 2025-04-01 | — | — | CN | disclosed |
| EP-4514315-A1 | SKIN CELL ENERGY BOOSTER COMPOSITION | CARBOCODE S.A. (PT) | 2025-03-05 | — | — | EP | disclosed |
| CN-115698164-B | Additive composition, resin composition containing the same, method for producing the same, and molded article | 株式会社ADEKA | 2024-09-17 | — | — | CN | disclosed |
| CN-118556106-A | Polyacetal resin composition | 旭化成株式会社 | 2024-08-27 | — | — | CN | disclosed |
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | CARBOCODE S.A. (PT) | 2024-07-18 | — | — | US | disclosed |
| EP-0456459-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1991-11-13 | — | — | EP | disclosed |
| EP-0261812-B1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1991-08-14 | — | — | EP | disclosed |
| EP-0435483-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1991-07-03 | — | — | EP | disclosed |
| US-4839161-A | 2-HYDROXYALKANOIC ACID OR ESTER AND SUNSCREEN; PREVENTS SUN-INDUCED DESQUAMATION | UNILEVER PATENT HOLDINGS B.V. (NL) | 1989-06-13 | — | — | US | disclosed |
| EP-0261812-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1988-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | UGCG, CERT1, CERS2 | GPR84 556/4885FFAR1 333/4885MAPT 1464/4885 |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | TLN1, PTK2, ILK | GPR84 1409/4885FFAR1 2050/4885MAPT 2055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.